Improving the Anticancer Efficacy of Laminin Receptor-Specific Therapeutic Ruthenium Nanoparticles (RuBB-Loaded EGCG-RuNPs) via ROS-Dependent Apoptosis in SMMC-7721 Cells

ACS Applied Materials and Interfaces

Volumn 8, Issue 24, 2016, Pages 15000-15012

  Zhou, Yanhui ^a   Yu, Qianqian ^a   Qin, Xiuying ^a   Bhavsar, Dhairya ^a   Yang, Licong ^a   Chen, Qingchang ^a   Zheng, Wenjing ^a   Chen, Lanmei ^a   Liu, Jie ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

67LR receptors; cellular targeting; fluorescence imaging; reactive oxygen species; ruthenium nanoparticles

Indexed keywords

BINDING ENERGY; CELL DEATH; CYTOLOGY; DISEASES; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; METAL NANOPARTICLES; MOLECULAR BIOLOGY; NANOPARTICLES; PARTICLE SIZE; RUTHENIUM; RUTHENIUM COMPOUNDS; TRANSMISSION ELECTRON MICROSCOPY;

67LR RECEPTORS; CELLULAR TARGETING; FLUORESCENCE IMAGING; REACTIVE OXYGEN SPECIES; RUTHENIUM NANOPARTICLES;

CELLS;

CATECHIN; LAMININ RECEPTOR; METAL NANOPARTICLE; REACTIVE OXYGEN METABOLITE; RUTHENIUM;

ANIMAL; APOPTOSIS; CELL LINE; HUMAN; MOUSE; NUDE MOUSE;

ANIMALS; APOPTOSIS; CATECHIN; CELL LINE; HUMANS; METAL NANOPARTICLES; MICE; MICE, NUDE; REACTIVE OXYGEN SPECIES; RECEPTORS, LAMININ; RUTHENIUM;

EID: 84975830611     PISSN: 19448244     EISSN: 19448252     Source Type: Journal    
DOI: 10.1021/acsami.5b02261     Document Type: Article

References (56)

1. Yang, J. D.; Roberts, L. R. Hepatocellular Carcinoma: a Global View Nat. Rev.Gastroenterol. Hepatol. 2010, 7, 448-458
2. Befeler, A. S.; Di Bisceglie, A. M. Hepatocellular Carcinoma: Diagnosis and Treatment Gastroenterology 2002, 122, 1609-19
3. El-Serag, H. B. Epidemiology Of Viral Hepatitis and Hepatocellular Carcinoma Gastroenterology 2012, 142, 1264-1273
4. Urakami, S.; Igawa, M.; Kikuno, N.; Yoshino, T.; Kishi, H.; Shigeno, K.; Shiina, H. Combination Chemotherapy with Paclitaxel, Estramustine and Carboplatin for Hormone Refractory Prostate Cancer J. Urol. 2002, 168, 2444-2450
5. Millikan, R.; Thall, P. F.; Lee, S. J.; Jones, D.; Cannon, M. W.; Kuebler, J. P.; Wade, J.; Logothetis, C. J. Randomized, Multicenter, Phase II Trial of two Multicomponent Regimens in Androgen-independent Prostate Cancer J. Clin. Oncol. 2003, 21, 878-883
6. Santoni, M.; Conti, A.; De Giorgi, U.; Iacovelli, R.; Pantano, F.; Burattini, L.; Muzzonigro, G.; Berardi, R.; Santini, D.; Cascinu, S. Risk of Gastrointestinal Events with Sorafenib, Sunitinib and Pazopanib in Patients with Solid Tumors: A Systematic Review and Meta-Analysis of Clinical Trials Int. J. Cancer 2014, 15, 763-773
7. Kim, J. H.; Scialli, A. R. Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease Toxicol. Sci. 2011, 122 (1) 1-6
8. Ferrara, N.; Hillan, K. J.; Gerber, H. P.; Novotny, W. Discovery and Development of Bevacizumab, an Anti-VEGF Antibody for Treating Cancer Nat. Rev. Drug Discovery 2004, 3, 391-400
9. Cabrera, R.; Pannu, D. S.; Caridi, J.; Firpi, R. J.; Soldevila-Pico, C.; Morelli, G.; Clark, V.; Suman, A.; George, T. J., Jr.; Nelson, D. R. The Combination of Sorafenib with Transarterial Chemoembolisation for Hepatocellular Carcinoma Aliment. Pharmacol. Ther. 2011, 34, 205-213
10. Zhong, J. H.; Ke, Y.; Gong, W. F.; Xiang, B. D.; Ma, L.; Ye, X. P.; Peng, T.; Xie, G. S.; Li, L. Q. Hepatic Resection Associated with Good Survival for Selected Patients with Intermediate and Advanced-Stage Hepatocellular Carcinoma Ann. Surg. 2014, 260 (2) 329-340
11. de Lope, C. R.; Tremosini, S.; Forner, A.; Reig, M.; Bruix, J. Management of HCC J. Hepatol. 2012, 56, S75-S87
12. Cheong, I.; Huang, X.; Bettegowda, C.; Diaz, L. A. J.; Kinzler, K. W.; Zhou, S. B. A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs Science 2006, 314, 308-311
13. Guan, M.; Zhou, Y.; Zhu, Q. L.; Liu, Y.; Bei, Y. Y.; Zhang, X. N.; Zhang, Q. N-trimethyl Chitosan Nanoparticle-Encapsulated Lactosyl-Norcantharidin for Liver Cancer Therapy with High Targeting Efficacy Nanomedicine 2012, 8, 1172-1181
14. De Bock, K.; Mazzone, M.; Carmeliet, P. Antiangiogenic Therapy, Hypoxia, and Metastasis: Risky Liaisons, or not? Nat. Rev Clin. Oncol. 2011, 8, 393-04
15. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding Biophysicochemical Interactions at the Nano-Bio Interface Nat. Mater. 2009, 8, 543-57
16. Misra, R.; Acharya, S.; Sahoo, S. K. Cancer Nanotechnology: Application of Nanotechnology in Cancer Therapy Drug Discovery Today 2010, 15, 842-850
17. Lee, I.; Kim, S.; Kim, S. N.; Jang, Y.; Jang, J. Highly Fluorescent Amidine/Schiff Base Dual-Modified Polyacrylonitrile Nanoparticles for Selective and Sensitive Detection of Copper Ions in Living Cells ACS Appl. Mater. Interfaces 2014, 6 (19) 17151-17156
18. Hoppens, M. A.; Sylvester, C. B.; Qureshi, A. T.; Scherr, T.; Czaps, D. R.; Duran, R. S.; Savage, P. B.; Hayes, D. Ceragenin Mediated Selectivity of Antimicrobial Silver Nanoparticles ACS Appl. Mater. Interfaces 2014, 6 (16) 13900-13908
19. Vigderman, L.; Zubarev, E. R. Therapeutic Platforms based on Gold Nanoparticles and their Covalent Conjugates with Drug Molecules Adv. Drug Delivery Rev. 2013, 65, 663-676
20. Kim, D.; Friedman, A. D.; Liu, R. Tetraspecific Ligand for Tumor-targeted Delivery of Nanomaterials Biomaterials 2014, 35, 6026-6036
21. Johnson, J. J.; Bailey, H. H.; Mukhtar, H. Green Tea Polyphenols for Prostate Cancer Chemoprevention: A Translational Perspective Phytomedicine 2010, 17, 3-13
22. Singh, B. N.; Shankar, S.; Srivastava, R. K. Green Tea Catechin, Epigallo-Catechin-3-Gallate (EGCG): Mechanisms, Perspectives and Clinical Applications Biochem. Pharmacol. 2011, 82 (12) 1807-1821
23. Forester, S. C.; Lambert, J. D. Synergistic Inhibition of Lung Cancer Cell Lines by (-)-Epigallocatechin-3-Gallate in Combination with Clinically used Nitrocatechol Inhibitors of Catechol-O-Methyltransferase Carcinogenesis 2014, 35, 365-372
24. Khan, N.; Afaq, F.; Mukhtar, H. Cancer Chemoprevention through Dietary Antioxidants: Progress and Promise Antioxid. Redox Signaling 2007, 10, 475-510
25. Yang, C. S.; Wang, X.; Lu, G.; Picinich, S. C. Cancer Prevention by Tea: Animal Studies, Molecular Mechanisms and Human Relevance Nat. Rev. Cancer 2009, 9 (6) 429-439
26. Siddiqui, I. A.; Adhami, V. M.; Bharali, D. J.; Hafeez, B. B.; Asim, M.; Khwaja, S. I.; Ahmad, N.; Cui, H. D.; Mousa, S. A.; Mukhtar, H. Introducing Nanochemoprevention as a Novel Approach for Cancer Control: Proof of Principle with Green Tea Polyphenol Epigallocatechin-3-Gallate Cancer Res. 2009, 69, 1712-1716
27. Khan, N.; Bharali, D. J.; Adhami, V. M.; Siddiqui, I. A.; Cui, H. D.; Shabana, S. M.; Mousa, S. A.; Mukhtar, H. Oral Administration of Naturally Occurring Chitosan-Based Nanoformulated Green Tea Polyphenol EGCG Effectively Inhibits Prostate Cancer Cell Growth in a Xenograft Model Carcinogenesis 2014, 35 (2) 415-423
28. Siddiqui, I. A.; Bharali, D. J.; Nihal, M.; Adhami, V. M.; Khan, N.; Chamcheu, J. C.; Khan, M. I.; Shabana, S.; Mousa, S. A.; Mukhtar, H. Excellent Anti-Proliferative and Pro-Apoptotic Effects of (-)-Epigallocatechin-3-Gallate Encapsulated in Chitosan Nanoparticles on Human Melanoma Cell Growth both in Vitro and in Vivo Nanomedicine 2014, 10, 1619-1626
29. Singh, M.; Bhatnagar, P.; Srivastava, A. K.; Kumar, P.; Shukla, Y.; Gupta, K. C. Enhancement of Cancer Chemosensitization Potential of Cisplatin by Tea Polyphenols Poly(Lactide-Co-Glycolide) Nanoparticles J. Biomed. Nanotechnol. 2011, 7 (1) 202-202
30. Shuklaa, R.; Chandaa, N.; Zambrea, A.; Upendranb, A.; Kattia, K.; Kulkarni, R. R.; Nune, S. K.; Casteel, S. W.; Smith, C. J.; Vimal, J.; Boote, E.; Robertson, J. D.; Kani; Para; Engelbrecht, H.; Watkinson, L. D.; Carmack, T. L.; Lever, J. R.; Cutler, C. S.; Caldwell, C.; Kannan, R.; Katti, K. V. Laminin Receptor Specific Therapeutic Gold Nanoparticles (198AuNP-EGCG) show Efficacy in Treating Prostate Cancer Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 12427-12431
31. Tachibana, H.; Koga, K.; Fujimura, Y.; Yamada, K. A. Receptor for Green Tea Polyphenol EGCG Nat. Struct. Mol. Biol. 2004, 11, 380-381
32. Menard, S.; Castronovo, V.; Tagliabue, E.; Sobel, M. E. New Insights into the Metastasis-Associated 67 Kd Laminin Receptor J. Cell. Biochem. 1997, 67, 155-165
33. Zheng, S.; Ruan, Y.; Wu, Z.; Tang, J. The Relationship between 67KD Laminin Receptor Expression and Metastasis of Hepatocellular Carcinoma J. Tongji Med. Univ. 1997, 17 (4) 200-202
34. Ozaki, I.; Yamamoto, K.; Mizuta, T.; Kajihara, S.; Fukushima, N.; Setoguchi, Y.; Morito, F.; Sakai, T. Differential Expression of Laminin Receptors in Human Hepatocellular Carcinoma Gut 1998, 43, 837-842
35. Sun, D.; Liu, Y.; Liu, D.; Zhang, R.; Yang, X.; Liu, J. Stabilization of G-quadruplex DNA, inhibition of Telomerase Activity and Live Cell Imaging Studies of Chiral Ruthenium(Ii) Complexes Chem.-Eur. J. 2012, 18, 4285-95
36. Liu, D.; Liu, Y.; Wang, C.; Shi, S.; Sun, D.; Gao, F.; Zhang, Q. L.; Liu, J. Polypyridyl Complexes Of Ruthenium(Ii): Stabilization of G-quadruplex DNA and Inhibition of Telomerase Activity ChemPlusChem 2012, 77, 497-7
37. Yang, L. C.; Zhang, J. N.; Wang, C.; Qin, X. Y.; Yu, Q. Q.; Zhou, Y. H.; Liu, J. Interaction between 8-Hydroxyquinoline Ruthenium(II) Complexes and Basic Fibroblast Growth Factors (bFGF): Inhibiting Angiogenesis and Tumor Growth through ERK and AKT Signaling Pathways Metallomics 2014, 6, 518-531
38. Sun, D.; Liu, Y.; Yu, Q.; Zhou, Y.; Zhang, R.; Chen, X. J.; Hong, A.; Liu, J. The Effects of Luminescent Ruthenium(II) Polypyridyl Functionalized Selenium Nanoparticles on bFGF-induced Angiogenesis and AKT/ERK Signaling Biomaterials 2013, 34, 171-80
39. Sun, D.; Liu, Y.; Yu, Q.; Qin, X.; Yang, L.; Zhou, Y.; Chen, L.; Liu, J. Inhibition of Tumor Growth and Vasculature and Fluorescence Imaging using Functionalized Ruthenium-Thiol Protected Selenium Nanoparticles Biomaterials 2014, 35, 1572-1583
40. Yang, L.; Chen, Q.; Liu, Y.; Zhang, J.; Sun, D.; Zhou, Y.; Liu, J. Se/Ru Nanoparticles as Inhibitors of Metal-induced Aβ Aggregation in Alzheimer's Disease J. Mater. Chem. B 2014, 2, 1977-1987
41. Puckett, C. A.; Barton, J. K. Fluorescein Redirects a Ruthenium-Octaarginine Conjugate to the Nucleus J. Am. Chem. Soc. 2009, 131, 8738-9
42. Lo, K. K. W.; Lee, T. K. M.; Lau, J. S. Y.; Poon, W. L.; Cheng, S. H. Luminescent Biological Probes Derived from Ruthenium(Ii) Estradiol Polypyridine Complexes Inorg. Chem. 2008, 47, 200-8
43. Li, C.; Yu, M.; Sun, Y.; Wu, Y.; Huang, C.; Li, F. A Nonemissive Iridium(Iii) Complex that Specifically Lights-Up the Nuclei of Living Cells J. Am. Chem. Soc. 2011, 133, 11231-11239
44. Llovet, J. M.; Burroughs, A.; Bruix, J. Hepatocellular Carcinoma Lancet 2003, 362, 1907-1917
45. Fang, J.; Nakamura, H.; Iyer, A. K. Tumor-Targeted Induction of Oxystress for Cancer Therapy J. Drug Targeting 2007, 15, 475-486
46. Manohar, M.; Fatima, I.; Saxena, R.; Chandra, V.; Sankhwar, P. L.; Dwivedi, A. -)-Epigallocatechin-3-Gallate Induces Apoptosis in Human Endometrial Adenocarcinoma Cells via ROS Generation and p38 MAP Kinase Activation J. Nutr. Biochem. 2013, 24, 940-947
47. Wang, C. T.; Chang, H. H.; Hsiao, C. H.; Lee, M. J.; Ku, H. C.; Hu, Y. J.; Kao, Y. H. The Effects of Green Tea (-)-Epigallocatechin-3-Gallate on Reactive Oxygen Species in 3T3-L1 Preadipocytes and Adipocytes depend on the Glutathione and 67 kDa Laminin Receptor Pathways Mol. Nutr. Food Res. 2009, 53, 349-360
48. Araki, S.; Dobashi, K.; Kubo, K.; Yamamoto, Y.; Shirahata, A. N-acetylcysteine Attenuates TNF-a Induced Changes in Secretion of Interleukin-6, Plasminogen Activator Inhibitor-1 and Adiponectin from 3T3-L1 Adipocytes Life Sci. 2006, 79, 2405-2012
49. Harrison, P. M.; Farzaneh, F. Regulation of HGF/SF Gene Expression in MRC-5 Cells by N-Acetylcysteine Biochem. Biophys. Res. Commun. 2000, 279, 108-115
50. Sinha, R.; El-Bayoumy, K. Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds Curr. Cancer Drug Targets 2004, 4, 13-28
51. Storz, P. Reactive Oxygen Species in Tumor Progression Front. Biosci. 2005, 10, 1881-1896
52. Alili, L.; Sack, M.; Montfort, C. v.; Giri, S.; Das, S.; Carroll, K. S.; Zanger, K.; Seal, S.; Brenneisen, P. Downregulation of Tumor Growth and Invasion by Redox-Active Nanoparticles Antioxid. Redox Signaling 2013, 19, 765-778
53. Tang, Y.; Zeng, X.; He, F.; Liao, Y.; Qian, N.; Toi, M. Caveolin-1 is related to Invasion, Survival, and Poor Prognosis in Hepatocellular Cancer Med. Oncol. 2012, 29, 977-984
54. Esme, H.; Cemek, M.; Sezer, M.; Saglam, H.; Demir, A.; Melek, H.; Unlu, M. High Levels of Oxidative Stress in Patients with Advanced Lung Cancer Respirology 2008, 13, 112-116
55. Luanpitpong, S.; Talbott, S. J.; Rojanasakul, Y.; Nimmannit, U.; Pongrakhananon, V.; Wang, L.; Chanvorachote, P. Regulation of Lung Cancer Cell Migration and Invasion by Reactive Oxygen Species and Caveolin-1 J. Biol. Chem. 2010, 285, 38832-38840
56. Hsieh, D. S.; Lu, H. C.; Chen, C. C.; Wu, C. J.; Yeh, M. K. The Preparation and Characterization of Gold-Conjugated Polyphenol Nanoparticles as a Novel Delivery System Int. J. Nanomed. 2012, 7, 1623-1633